# siRNA Loaded-Exosomes 修饰外泌体作为siRNA递送载体靶向大脑的研究

María Izco and Lydia Alvarez-Erviti

## Abstract 摘要

Exosomes are membrane-bound vesicles (40–100 nm) of endocytic origin released by numerous cell types that act as natural carriers of mRNA, microRNA, and proteins between cells. We developed a new system that uses intravenous injection of modified exosomes for siRNA delivery into the brain. Here we describe the generation of unmodified and modified exosomes, which specifically target the brain, and the method to load siRNA into the exosomes.

<span style=color:blue>外泌体是由多种细胞类型释放的膜结合小泡（40-100 nm），它们通过内吞作用形成，能够作为天然载体将mRNA、microRNA和蛋白质在细胞之间传递。我们开发了一种新系统，利用静脉注射修饰过的外泌体将siRNA传递到大脑。本文描述了如何生成未修饰和修饰过的外泌体，这些外泌体能够特异性地靶向大脑，并详细介绍了将siRNA加载到外泌体中的方法。</span>

## 1 Introduction 前言

Knockdown of gene expression has clear potential for treatment of many diseases and small interfering RNAs (siRNAs) specific to a chosen target can be designed readily. However, the use of siRNAs requires a vehicle that delivers the gene therapy molecules specifically and safely into the target tissue. This question is especially relevant for the treatment of diseases affecting the central nervous system. However, one of the major challenges facing this approach is the development of a vehicle which allows a safe and effective delivery of the therapeutic agent to the dispersed regions of the brain where knockdown would be required. The brain is a particularly difficult target for drugs of all classes because the blood–brain barrier excludes most drugs larger than 400 Da. The ideal treatment should be minimally invasive, delivered specifically and safely into the brain following peripheral administration, and not be hindered by immune inhibition. None of the approaches using viral vector or liposomes fulfill these requirements. The use of viral vector requires stereotaxic surgery and the delivery is restricted to restricted brain regions. Liposomes activate the immune response, which mediates the rapid clearance of liposomes in subsequent administration reducing significantly the efficacy in long-term treatments. To overcome these problems, we developed a new system that uses intravenous (iv) injection of modified exosomes for nucleic acid delivery into the brain. Exosomes are membrane-bound vesicles (40–100 nm) of endocytic origin released by numerous cell types that act as natural carriers of mRNA, microRNA, and proteins between cells. We have designed and generated modified exosomes, which specifically target the brain, by placing a brain targeting peptide (RVG peptide, rabies virus glycoprotein peptide) in the exterior of the exosome and developed them as a novel system to deliver genetic material into the brain after intravenous injection. A schematic representation of the production, harvest, and administration of targeted RVG-exosomes for gene delivery is shown in Fig.1. Using this system to deliver siRNAs we have obtained remarkably effective knockdown expression of a number of targets in mouse brains after tail vein injection.

<span style=color:blue>基因表达敲低在治疗多种疾病方面具有明确的潜力，而且可以方便地设计针对特定靶点的小干扰RNA（siRNA）。然而，siRNA的使用需要一种载体，能够将基因治疗分子特异性和安全地输送到目标组织中。这一问题在治疗影响中枢神经系统的疾病时尤为重要。面临的主要挑战之一是开发一种载体，能够安全且有效地将治疗药物输送到大脑的不同区域，而这些区域需要进行基因敲低。大脑是所有药物类别中最难以靶向的目标，因为血脑屏障排斥大多数分子量大于400 Da的药物。理想的治疗方法应当是微创的，能够在外周给药后，特异性且安全地将药物输送到大脑，并且不受免疫抑制的影响。然而，现有的病毒载体和脂质体方法无法满足这些需求。病毒载体需要立体定向手术，并且只能将药物输送到大脑的特定区域。脂质体则会激活免疫反应，导致脂质体在后续给药中的快速清除，从而大大降低长期治疗的效果。为了解决这些问题，我们开发了一种新系统，使用静脉注射修饰外泌体将核酸送入大脑。外泌体是来源于内吞作用的膜结合小泡（40–100 nm），由多种细胞类型释放，并作为天然载体在细胞之间传递mRNA、microRNA和蛋白质。我们通过将靶向大脑的肽（RVG肽，狂犬病毒糖蛋白肽）附加在外泌体的外表面，设计并生成了特异性靶向大脑的修饰外泌体，并将其作为一种新系统，利用静脉注射将遗传物质送入大脑。图1展示了靶向RVG-外泌体用于基因输送的生产、收集和给药流程示意图。利用该系统输送siRNA，我们在小鼠尾静脉注射后，成功实现了对多个靶基因的显著敲低效果。</span>

![485053_1_En_21_Fig1_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_21_Fig1_HTML.png)

**Fig. 1** Schematic representation of production, harvest, and administration of targeted RVG-exosomes for gene delivery

## 2 Materials 材料

Use only sterile reagents for all the procedures. Use fetal calf serum (FCS) depleted of exosomes by centrifugation at 120,000 × *g* for 90 min or commercial exosome free FCS.

<span style=color:blue>所有操作过程中请确保使用无菌试剂。使用通过120,000 × *g* 离心90分钟去除外泌体的胎牛血清（FCS），或者使用市售去除外泌体的FCS。</span>

1. 70% Ethanol. <span style=color:blue>70% 乙醇</span>
2. 10 cm Petri dish.<span style=color:blue>10 cm 佩特里培养皿</span>
3. Forceps, scalpel, and scissor.<span style=color:blue>镊子、手术刀和剪刀</span>
4. 10 mL Syringe.<span style=color:blue>10 mL 注射器</span>
5. 21G, 25G, and 27G needles.<span style=color:blue>21G、25G 和 27G 针头</span>
6. 50 mL Falcon tube.<span style=color:blue>50 mL 法尔肯管</span>
7. Benchtop centrifuge.<span style=color:blue>台式离心机</span>
8. Red blood cell buffer lysis: 155 mM ammonium chloride, 10 mM sodium bicarbonate, 0.1 mM EDTA.<span style=color:blue>红细胞裂解缓冲液：155 mM 氯化铵、10 mM 碳酸氢钠、0.1 mM EDTA</span>
9. Dendritic cell culture medium: supplementing DMEM Glutamax medium with 10% FCS and antibiotics (penicillin/streptomycin, 10,000 U/mL).<span style=color:blue>树突状细胞培养基：使用10%胎牛血清（FCS）和抗生素（青霉素/链霉素，10,000 U/mL）补充DMEM Glutamax培养基</span>
10. Murine granulocyte-macrophage colony stimulating factor (GM-CSF).<span style=color:blue>小鼠粒细胞-巨噬细胞集落刺激因子（GM-CSF）</span>
11. 6-Well plates.<span style=color:blue>6孔培养板</span>
12. Lamp2b-RVG plasmid DNA .<span style=color:blue>Lamp2b-RVG质粒DNA</span>
13. TransIT LT1 transfection reagent (Mirus).<span style=color:blue>TransIT LT1 转染试剂（Mirus）</span>
14. Polycarbonate sterile tube.<span style=color:blue>聚碳酸酯无菌管</span>
15. Ultracentrifuge or benchtop ultracentrifuge.<span style=color:blue>超速离心机或台式超速离心机</span>
16. 0.1 M Ammonium acetate.<span style=color:blue>0.1 M 醋酸铵</span>
17. Nanoparticle tracking analysis equipment. <span style=color:blue>纳米颗粒跟踪分析设备</span>
18. Sterile PBS.<span style=color:blue>无菌PBS</span>
19. Transmission electron microscopy (TEM), scanning electron microscopy (SEM), or cryo-electron microscopy.<span style=color:blue>透射电子显微镜（TEM）、扫描电子显微镜（SEM）或冷冻电子显微镜</span>
20. Osmium tetraoxide.<span style=color:blue>四氧化锇</span>
21. Phosphotungstic acid.<span style=color:blue>磷钨酸</span>
22. Cooper grid.<span style=color:blue>铜网</span>
23. NuPAGE Novex 4%–12% Bis-Tris Gel (Invitrogen).<span style=color:blue>NuPAGE Novex 4%–12% Bis-Tris 凝胶（Invitrogen）</span>
24. BCA assay kit.<span style=color:blue>BCA蛋白定量试剂盒</span>
25. Electroporation mix: Mix 400 nM (in vitro assays) or 12 μg (in vivo assays) siRNA, 12 μg exosomes and 400 μL electroporation buffer.<span style=color:blue>电穿孔混合液：将400 nM（体外实验）或12 μg（体内实验）siRNA、12 μg外泌体和400 μL电穿孔缓冲液混合</span>
26. Electroporation buffer: 1.15 mM potassium phosphate (pH 7.2), 25 mM potassium chloride, 21% optiprep (iodixanol).<span style=color:blue>电穿孔缓冲液：1.15 mM 磷酸钾（pH 7.2），25 mM 氯化钾，21% optiprep（碘克沙醇）</span>
27. Gene pulse cuvettes 0.4 mm (Bio-Rad).<span style=color:blue>Gene Pulse 0.4 mm 电穿孔比色皿（Bio-Rad）</span>
28. Electroporator: Gene Pulse Xcell electroporation system (Bio-Rad).<span style=color:blue>电穿孔仪：Gene Pulse Xcell 电穿孔系统（Bio-Rad）</span>
29. 5% Glucose.<span style=color:blue>5% 葡萄糖</span>
30. siRNA.

## 3 Methods 方法

### 3.1 Dendritic Cell Primary Culture 树突状细胞原代培养

This section details the procedure for dendritic cell isolation . Alternatively, other cell sources including primary cell and cell lines could be used as source of exosomes.

<span style=color:blue>本节介绍了树突状细胞的分离方法。除了树突状细胞外，其他细胞来源，如原代细胞或细胞系，也可以用来作为外泌体的来源。</span>

1. Euthanize mice and disinfect using 70% ethanol (*see* **Note** **1**).<span style=color:blue>安乐死小鼠，并使用70%乙醇消毒 (*参见**注释** 1**)。</span>
2. Remove femurs and tibias from euthanized mice in a cell culture hood and place the bones in a 10 cm Petri dish (*see* **Note** **2**).<span style=color:blue>在细胞培养罩中取出小鼠的股骨和胫骨，并将其放入一个10厘米的培养皿中 (*参见**注释** 2**)。</span>
3. Remove all the rest of muscle and tendons using a scalpel and transfer the clean bones to a new Petri dish.<span style=color:blue>用手术刀去除小鼠骨头上的肌肉和韧带，并将清洁的骨头转移到新的培养皿里。</span>
4. Cut off both ends of the bone using a scissor and flush off the bone marrow in a new Petri dish with dendritic cell medium using a 10 mL syringe and 21G needle for femur or a 25G needle for tibia.<span style=color:blue>用剪刀切掉骨头两端，使用10 mL注射器和21G针头（对于股骨）或25G针头（对于胫骨），在新培养皿中用树突状细胞培养基冲洗骨髓。</span>
5. Collect the cell suspension in a sterile 50 mL Falcon tube. Centrifuge at 300 × *g* for 10 min and discard the supernatant.<span style=color:blue>将收集到的细胞悬液转移到无菌的50 mL Falcon管中，进行300 × *g* 10分钟的离心，去除上清液。</span>
6. Resuspend the pellet with red blood cell (RBC) lysis buffer (1–2 mL per mouse) and incubate for 5 min at room temperature. Add 5 mL of dendritic cell medium per mL of RBC lysis buffer, centrifuge at 300 × *g* for 10 min, and discard the supernatant <span style=color:blue>用红细胞裂解缓冲液（每只小鼠1–2 mL）重悬细胞沉淀，在室温下孵育5分钟。每mL红细胞裂解缓冲液加入5 mL树突状细胞培养基，再次离心300 × *g* 10分钟，弃去上清液。</span>
7. Resuspend the pellet in 10 mL of dendritic cell medium, centrifuge at 300 × *g* for 10 min, and discard the supernatant.<span style=color:blue>将沉淀重悬在10 mL树突状细胞培养基中，进行300 × *g* 10分钟离心，再次弃去上清液。</span>
8. Resuspend the pellet with dendritic cell medium supplemented with 10 μg/mL murine GM-CSF and adjust the cell concentration to 106 cell/mL. Plate 3 mL of the cell suspension per well in a six-well plates (*see* **Note** **3**). <span style=color:blue>将沉淀重悬于含10 μg/mL小鼠GM-CSF的树突状细胞培养基中，并调整细胞浓度至10^6 细胞/mL。将3 mL细胞悬液加入到六孔板的每个孔中 (*参见**注释** 3**)。</span>
9. On day 4 transfect the dendritic cells. Prepare the transfection mix adding 6 μg of Lamp2b-RVG plasmid DNA, 6 μL of TransIT LT1 transfection reagent and plain DMEM medium up to 600 μL transfection mix per well, incubate for 20 min at room temperature. Remove the medium from the 6-well plates, replace with 3 mL of dendritic cell medium per well, and add 600 μL of transfection mix. After 4 h remove the medium and replace with 3 mL of dendritic cell medium supplemented with 10 μg/mL GM-CSF (*see* **Note** **4**). <span style=color:blue>在第4天进行树突状细胞转染。准备转染混合液，加入6 μg Lamp2b-RVG质粒DNA、6 μL TransIT LT1转染试剂和适量的DMEM培养基，最终使每孔的转染混合液体积达到600 μL，室温孵育20分钟。去除六孔板中的培养基，换成每孔3 mL树突状细胞培养基，并加入600 μL转染混合液。4小时后，去除培养基，并换成含10 μg/mL GM-CSF的树突状细胞培养基 (*参见**注释** 4**)。</span>
10. On day 7 remove the medium and replace with 1.5–2 mL of dendritic cell medium per well.<span style=color:blue>在第7天，去除培养基，并换成每孔1.5–2 mL树突状细胞培养基。</span>

### 3.2 Exosome Isolation 外泌体分离

1. Collect the medium from the 6-well plate and centrifuge at 300 × *g* for 10 min. <span style=color:blue>从6孔板收集培养基，并以300 × *g* 离心10分钟。</span>
2. Transfer the supernatant to a polycarbonate sterile tube and centrifuge at 12,000 × *g* for 30 min. <span style=color:blue>将上清液转移到聚碳酸酯无菌管中，并以12,000 × *g* 离心30分钟。</span>
3. Transfer the supernatant to a polycarbonate sterile tube and centrifuge at 12,0000 × *g* for 60 min. <span style=color:blue>将上清液再次转移至聚碳酸酯无菌管中，并以12,0000 × *g* 离心60分钟。</span>
4. Resuspend the exosomes in 0.1 M ammonium acetate with a 27G syringe, use 30–40 μL per mice (*see* **Note** **5**).<span style=color:blue>使用27G注射器将外泌体重悬于0.1 M醋酸铵中，每只小鼠注射30-40 μL（*参见* **注释** **5**）。</span>

### 3.3 Exosome Characterization and Quantitation 外泌体表征与定量

1. Exosome characterization by Nanoparticle Tracking Analysis (NTA): The NTA analysis provides data about nanoparticle size distribution and concentration. Dilute the exosomes in sterile PBS before measure; prepare an initial 1:100 dilution, if necessary, prepare serial 1:10 dilutions. For analysis collect 30–60 second videos (3–5 replicates per sample). <span style=color:blue>外泌体表征：纳米颗粒追踪分析（NTA）法：该方法提供了纳米颗粒的大小分布和浓度数据。在测量之前，先将外泌体稀释在无菌PBS中，通常先准备1:100的初始稀释液，如有需要可进行1:10的连续稀释。进行测量时，采集30-60秒的视频，每个样品重复3-5次。</span>
2. Exosome characterization by electron microscopy: Transmission electron microscopy (TEM), scanning electron microscopy (SEM), or cryo-electron microscopy could be used to observe exosomes. Electron microscopy provides images to monitor the size, quality, and purity of the exosomes population. Incubate the exosomes with 4% osmium tetraoxide for 30 min at 4 ° C, apply onto a copper grid, and stain with 1% phosphotungstic acid solution (pH 7) for 10 min. <span style=color:blue>外泌体通过电子显微镜进行表征：可以使用透射电子显微镜（TEM）、扫描电子显微镜（SEM）或低温电子显微镜来观察外泌体。电子显微镜图像有助于监控外泌体的大小、质量和纯度。将外泌体与4%的四氧化锇溶液孵育30分钟，保持在4°C，用1%磷钨酸溶液（pH 7）染色10分钟，并应用在铜网格上。</span>
3. Western blot : Detection of exosome-enriched proteins is used to characterize and confirm exosome identity. It is necessary to confirm the presence of several protein markers, because no specific proteins have been identified to distinguish exosomes from other extracellular vesicles. Commonly used exosomal markers are Alix, Flotillin-1, TSG101, CD9, CD63, CD81, and hsp70. Solubilize the samples and load a minimal amount of 5 μg total protein, separate on Bis-Tris gel and analyze by Western blot.<span style=color:blue>Western blot分析：通过检测外泌体富集的蛋白质来表征并确认外泌体的身份。因为目前还没有特异性蛋白可以区分外泌体与其他类型的细胞外小泡，因此需要确认多个标志性蛋白的存在。常用的外泌体标志物包括Alix、Flotillin-1、TSG101、CD9、CD63、CD81和hsp70。溶解样品，加载至少5 μg的总蛋白，通过Bis-Tris凝胶分离，并使用Western blot进行分析。</span>
4. Quantify the protein content by BCA assay. <span style=color:blue>采用BCA法定量蛋白含量。</span>

### 3.4 siRNA Loading into Exosomes siRNA加载到外泌体

1. Prepare the electroporation mix (*see* **Note** **6**). <span style=color:blue>准备电转混合液 (*见* **注释** **6**)。</span>
2. Electroporate the mix in a 4 mm cuvette with 400 V and 125 mA of capacitance. To prepare larger quantities of siRNA-electroporated exosomes, prepare the electroporation mix and electroporate 400–600 μL at a time. <span style=color:blue>将混合液在4 mm电池中进行电转，使用400 V和125 mA的电容量。如果需要更大量地制备siRNA电转的外泌体，可以准备电转混合液，每次电转400–600 μL。</span>
3. Isolate the electroporated exosomes transferring the electroporation mix to an ultracentrifugation tube and add PBS to fill the tube, centrifuge at 12,0000 × *g* for 60 min. <span style=color:blue>通过将电转混合液转移到超速离心管中，并加入PBS至填满管体，然后进行超速离心（条件为12,0000 × *g*，离心时间60分钟），从而分离电转后的外泌体。</span>
4. Resuspend the exosomes with a 27G syringe in medium for in vitro experiments or in 5% glucose for in vivo experiments. <span style=color:blue>使用27G注射器将外泌体重悬，若用于体外实验，使用培养基；若用于体内实验，使用5%葡萄糖溶液。</span>
5. Electroporation conditions need to be optimized if a different electroporation buffer or electroporator is used. Alternatively, siRNA could be loaded into exosomes by pH gradient modification, sonication, or calcium chloride (*see* **Note** **7**). <span style=color:blue>如果使用不同的电转缓冲液或电转仪器，电转条件需要进一步优化。另一种选择是通过pH梯度修饰、超声波处理或氯化钙方法将siRNA加载到外泌体中 (*见* **注释** **7**)。</span>

### 3.5 Assessment of siRNA Loading into Exosomes siRNA加载到外泌体中的评估

To quantify the efficiency of exosome-mediated siRNA delivery in vitro, use a target cell line. Incubate the cells with the siRNA-loaded exosomes for 48–72 h. As control use the same amount of siRNA (100 nM) delivered using a conventional transfection reagent. Targeted mRNA and protein downregulation should be similar or higher in the cells treated with siRNA-loaded exosomes. mRNA expression levels could be analyzed by RT-PCR and protein levels by Western blot.<span style=color:blue>为了定量评估外泌体介导的siRNA输送效率，可以选用靶细胞系进行实验。将siRNA加载的外泌体与细胞共同培养48–72小时。作为对照，使用常规转染试剂将相同量（100 nM）的siRNA导入细胞。处理过siRNA加载外泌体的细胞应显示出与常规转染方法相似或更强的靶向mRNA和蛋白质下调效果。可以通过RT-PCR分析mRNA的表达水平，通过Western blot检测蛋白质水平。</span>

## 4 Notes 注释

1. The average amount of exosomes isolated from the primary dendritic cell isolated from 1 mouse is 40–60 μg. Use mice 8–18 weeks old for dendritic cell primary culture . <span style=color:blue>从1只小鼠分离的原代树突状细胞中获得的外泌体平均量为40-60 μg。建议使用8-18周龄的小鼠进行树突状细胞的原代培养。</span>
2. Bone marrow is the best source of dendritic cells in animal models, and femur and tibias are the best bones to isolate bone marrow. If the cell culture hood is located in the animal facilities place the bones in a sterile 50 mL Falcon tube and continue the procedure in the cell culture facilities. <span style=color:blue>骨髓是动物模型中树突状细胞的最佳来源，股骨和胫骨是分离骨髓的最佳部位。如果细胞培养台位于动物实验区，可将骨骼放入无菌的50 mL Falcon管中，并将后续操作移至细胞培养室进行。</span>
3. Murine bone marrow-derived dendritic cells can be generated using GM-CSF alone or in conjunction with interleukin-4 (IL-4).<span style=color:blue>小鼠骨髓来源的树突状细胞可以仅使用GM-CSF，或与白介素-4（IL-4）联合使用来生成。</span>
4. The transfection of the dendritic cells with the Lamp2b-RVG plasmid is necessary to obtain brain-targeted exosomes. Use a different targeting peptide to direct exosomes to other organ targets. Alternatively to produce non-targeted exosomes just replace the medium on day 4 with 3 mL medium supplemented with 10 μg/mL GM-CSF. <span style=color:blue>为了获得靶向大脑的外泌体，必须将Lamp2b-RVG质粒转染到树突状细胞中。如果需要将外泌体定向至其他器官靶标，可以使用不同的靶向肽。另一种方法是生成非靶向外泌体，只需在第4天更换培养基，补充10 μg/mL GM-CSF。</span>
5. There are different techniques to isolate exosomes from cell culture medium. Differential ultracentrifugation allows exosomes isolation from large volumes of biological fluids, requires a relatively small set of reagents and consumables, and has good reproducibility. Alternatively, use commercial isolation reagents or kits based on size exclusion chromatography and precipitation. <span style=color:blue>有多种方法可以从细胞培养基中分离外泌体。差速超高速离心法是一种常见的技术，它可以从大量生物液体中分离外泌体，所需的试剂和耗材较少，且具有较好的可重复性。也可以使用基于尺寸排阻色谱或沉淀法的商业分离试剂或试剂盒。</span>
6. If a different source of exosomes or a modified siRNA is used, confirm the optimal amount of exosomes necessary to load and deliver the siRNA. The ratio of siRNA-exosomes is fundamental to obtain an optimal loading.<span style=color:blue>如果使用不同来源的外泌体或修改过的siRNA，需要确认加载和递送siRNA所需的外泌体的最佳量。siRNA与外泌体的比例是实现最佳加载的关键因素。</span>
7. Electroporation ensures that loaded exosomes maintain the characteristics and deliver safely and effectively siRNA in vivo. Alternative methods to load siRNA into exosomes have been developed, to avoid unexpected results associated to the loading method characterize exosomes, effectivity, safety and immune response in the initial experiments.<span style=color:blue>电穿孔法能够确保加载的外泌体保持其特性，并在体内安全有效地递送siRNA。为了避免加载方法带来的不确定性，已开发出替代的加载方法，建议在初步实验中对外泌体的效果、安全性、免疫反应等进行表征。</span>